Internal Medicine, Pulmonary Disease · Oklahoma City, OK
NPI
1689863953
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3300 NW Expressway Fl 4
Oklahoma City, OK, 73112
Phone (405) 949-3349
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,447 services
Medicare patients, 2024
339
Average age 72
Drug cost, 2024
$37.3M
6,394 prescriptions
Company payments, 2025
$49K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Kingrey was code 99214 (office e&m - established), 229 times for 163 patients. In total John Kingrey billed 1,447 services in 32 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 229 | 163 | $66.49 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 32 | $88.31 | $10K |
| 94726 Pulmonary Function Testing | Facility | 103 | 91 | $8.16 | $840 |
| 94060 Pulmonary Function Testing | Facility | 103 | 90 | $6.99 | $720 |
| 94729 Pulmonary Function Testing | Facility | 103 | 91 | $6.11 | $630 |
| 99215 Office E&M - Established | Facility | 90 | 70 | $95.37 | $8,584 |
| 94618 Pulmonary Function Testing | Facility | 82 | 66 | $14.50 | $1,189 |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 31 | $58.77 | $4,466 |
| 99214 Office E&M - Established | Office | 60 | 54 | $88.95 | $5,337 |
| 93451 Percutaneous Transcatheterization | Facility | 56 | 54 | $91.39 | $5,118 |
| 76937 Ultrasound - Nonspecific | Facility | 54 | 52 | $10.11 | $546 |
| 99152 Anesthesia | Facility | 44 | 43 | $8.91 | $392 |
| 99291 Critical Care E&M | Facility | 38 | 14 | $158.47 | $6,022 |
| 99213 Office E&M - Established | Facility | 34 | 32 | $47.12 | $1,602 |
| 99223 Hospital E&M - Initial | Facility | 32 | 26 | $123.05 | $3,938 |
By year: 2022 $74K for 1,321 services; 2023 $86K for 1,113 services; 2024 $83K for 1,447 services.
Medicare prescription drug claims, 2024
In 2024, the drug John Kingrey prescribed most often to Medicare patients was Opsumit (Macitentan), with 800 prescriptions and refills. In total John Kingrey wrote 6,394 Medicare prescriptions that cost $37.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 800 | 800 | 88 | $10.0M |
| Tadalafil Generic | 476 | 502 | 58 | $153K |
| Spironolactone Generic | 439 | 783 | 103 | $3,428 |
| Furosemide Generic | 431 | 738 | 96 | $2,712 |
| Potassium Chloride Generic | 405 | 701 | 92 | $12K |
| Orenitram Er Treprostinil Diolamine | 378 | 378 | 21 | $5.3M |
| Adempas Riociguat | 376 | 376 | 37 | $5.1M |
| Uptravi Selexipag | 351 | 351 | 40 | $7.7M |
| Sildenafil Citrate Generic | 260 | 347 | 43 | $30K |
| Torsemide Generic | 217 | 390 | 51 | $5,132 |
| Tyvaso Dpi Treprostinil | 205 | 205 | 25 | $4.9M |
| Ambrisentan Generic | 189 | 189 | 23 | $486K |
| Eliquis Apixaban | 173 | 243 | 30 | $137K |
| Pantoprazole Sodium Generic | 128 | 263 | 34 | $1,595 |
| Prednisone Generic | 90 | 115 | 42 | $495 |
Brand drugs: 3,058 claims; generic drugs: 3,336 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Kingrey $49K ($49K in general payments such as food, travel and fees) from 8 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 28 | $24K |
| Merck Sharp & Dohme LLC MRK | 21 | $17K |
| United Therapeutics Corporation UTHR | 13 | $8,580 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.1 |
| Abbott Laboratories ABT | 1 | $23.44 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $19.15 |
| GlaxoSmithKline, LLC. GSK | 1 | $14.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.